Patent directory · USPTO A61K / A61P
Patents matching “REGENERON PHARMACEUTICALS, INC.”
837 pharma patents match "REGENERON PHARMACEUTICALS, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 837 pharmaceutical patents matching "REGENERON PHARMACEUTICALS, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12010979
Non-human animals comprising a humanized TTR locus and methods of use
granted -
US 12012444
Anti-VEGF protein compositions and methods for producing the same
granted -
US 12012445
Anti-VEGF protein compositions and methods for producing the same
granted -
US 11999777
Methods for treating or preventing SARS-CoV-2 infections and COVID-19 with anti-SARS-CoV-2 spike glycoprotein antibodies
granted -
US 12000839
Methods for characterizing disulfide bonds
granted -
US 11999799
Anti-TMPRSS2 antibodies and antigen-binding fragments
granted -
US 11986511
Use of a VEGF antagonist to treat angiogenic eye disorders
granted -
US 11975045
Use of a VEGF antagonist to treat angiogenic eye disorders
granted -
US 11965161
Methods and compositions for sensitization of tumor cells to immune therapy
granted -
US 11964016
Combination of IL-4/IL-13 pathway inhibitors and plasma cell ablation for treating allergy
granted -
US 11965020
Antigen binding molecule formats
granted -
US 11958910
Bispecific antigen binding molecules that bind HER2, and methods of use thereof
granted -
US 11957687
Modulators of HSD17B13 and methods of use thereof
granted -
US 11958894
Anti-VEGF protein compositions and methods for producing the same
granted -
US 11957704
Methods of treating metabolic disorders and cardiovascular disease with inhibin subunit beta E (INHBE) inhibitors
granted -
US 11951216
Polymer protein microparticles
granted -
US 11944666
Treatment of inflammatory conditions delivery of interleukin-1 receptor antagonist fusion protein
granted -
US 11945872
Anti-ACVR1 antibodies and uses thereof
granted -
US 11932692
Methods of treating cancer pain by administering a PD-1 inhibitor
granted -
US 11926668
Anti-PD-1 antibodies for treatment of lung cancer
granted -
US 11926670
Stabilized formulations containing anti-interleukin-4 receptor (IL-4R) antibodies
granted -
US 11926661
Human antibodies to artemin and methods of use thereof
granted -
US 11919972
Peptide libraries with non-canonical amino acids
granted -
US 11919965
Methods of treating multiple myeloma with bispecific anti-BCMA x anti-CD3 antibodies
granted